CAPTURE-R READY ID
Report
- Report Number
- 1034569-2008-00272
- Event Type
- Malfunction
- Date Received
- July 25, 2008
- Date of Event
- June 26, 2008
- Report Date
- July 17, 2008
- Manufacturer
- IMMUCOR, INC.
- Product Code
- KSZ
- PMA / PMN Number
- 102707 STN
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
REACTIIVTY OF THE FYA ANTIGEN WAS CONFIRMED ON RETENTION CRRS, LOT K121 AND CRRID, LOT ID079. THE CUSTOMER'S RETURNED SAMPLES WERE TESTED BY HA WITH SELECTED FY(A+B+) AND FY(A-) REAGENT RED CELLS, USING IMMUADD, LOT 5B5503, AS THE POTENTIATOR. VERY WEAK REACTIVITY WAS OBSERVED WITH BOTH SAMPLES WITH FY(A+B+) CELL AT IAT. THE FY(A-) CELL WAS NONREACTIVE, AS EXPECTED. MANUAL SOLID PHASE TESTING WAS PERFORMED WITH THE CUSTOMER'S SAMPLES AND RETENTION CRRS, LOT K121, FY(A+B-) CELL III AND FY(A-) CELL IV AND CRRID, LOT ID079 FY(A+B+) CELL 2; FY(A-B-) CELL 4, AND FY(A+B-) CELL 6. ALL FY(A-) CELLS WERE NONREACTIVE, AS EXPECTED. ONE SAMPLE EXHIBITED VERY WEAK TO WEAK REACTIVITY WITH FY(A+B) CELLS AND NONREACTIVITY WITH FY(A+B+) CELLS. THE OTHER SAMPLE EXHIBITED NEGATIVE TO WEAK REACTIVITY WITH FY(A+B-) CELLS AND NONREACTIVITY WITH FY(A+B+) CELLS. THE CUSTOMER DID NOT RETURN PRODUCT FOR INVESTIGATION. THE PATIENT'S ANTIBODY IS SHOWING DOSAGE EFFECT; THE EVENT APPEARS TO BE CAUSED BY THE NATURE OF THE SAMPLE. THE PACKAGE INSERTS FOR CAPTURE-R READY ID AND CRRS 4 STATE "NEGATIVE REACTIONS WILL BE OBTAINED IF THE TEST SERUM CONTAINS ANTIBODIES PRESENT IN CONCENTRATIONS TOO LOW TO BE DETECTED BY THE TEST METHODS EMPLOYED."
CUSTOMER REPORTED A FALSE NEGATIVE REACTION WITH CAPTURE R READY SCREEN (CRRS) 4 ON GALILEO. A PATIENT SAMPLE KNOWN TO CONTAIN ANTI-FYA WAS NEGATIVE WHEN TESTED WITH CRRS 4.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CAPTURE-R READY ID | REAGENT RED BLOOD CELLS | KSZ | IMMUCOR, INC. | ID079 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |